Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Intelerad
HQ Canada · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Mar 2026: GE HealthCare completed its US$2.3bn cash acquisition of Intelerad, which now sits within GE HealthCare's Imaging business; the deal was announced in Nov 2025. Buyers should note the change of ownership.
Cyber & information governance
Sep 2026: Intelerad issued a software correction for certain InteleradPACS versions after finding a vulnerability in the InteleBrowser admin portal that could let an authenticated user gain administrator access. NHS DSPT status not yet checked.
Regulatory & clinical safety
Sep 2026: A PACS software correction (recall) was notified in New Zealand covering a security flaw and a rare image-deletion issue in a non-default cloud archive setup; the manufacturer found no evidence that setup is used in production.
Contract performance
Jan 2025: Intelerad was awarded the West of England Imaging Network framework (PACS, RIS, image sharing and storage) for seven NHS trusts, valued at £49.85m excluding VAT.
Competitors
No competitors linked yet.